oxfordbiomaterials.com
Oxfordbiomaterials LtdOxford Biomaterials Ltd is a platform technology company developing silk-based products. One of the first and main areas of interest is silk-based medical implants.
http://www.oxfordbiomaterials.com/
Oxford Biomaterials Ltd is a platform technology company developing silk-based products. One of the first and main areas of interest is silk-based medical implants.
http://www.oxfordbiomaterials.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
0.5 seconds
16x16
32x32
BT Business Internet Services
BT Business Domains
81 New●●●●●●Street
Lo●●on , GB, EC1 7AJ
GB
View this contact
BT Business Internet Services
BT Business Domains
81 New●●●●●●Street
Lo●●on , England, EC1 7AJ
GB
View this contact
BT Business Internet Services
BT Business Domains
81 New●●●●●●Street
Lo●●on , GB, EC1 7AJ
GB
View this contact
19
YEARS
6
MONTHS
28
DAYS
REGISTER.COM, INC.
WHOIS : whois.register.com
REFERRED : http://www.register.com
PAGES IN
THIS WEBSITE
8
SSL
EXTERNAL LINKS
7
SITE IP
172.217.10.147
LOAD TIME
0.484 sec
SCORE
6.2
Oxfordbiomaterials Ltd | oxfordbiomaterials.com Reviews
https://oxfordbiomaterials.com
Oxford Biomaterials Ltd is a platform technology company developing silk-based products. One of the first and main areas of interest is silk-based medical implants.
Oxfordbiomaterials Ltd
http://www.oxfordbiomaterials.com/home
Silk for the 21st Century. Oxford Biomaterials Ltd - Magdalen Centre, Oxford Science Park, OX4 4GA, Oxford, UK.
Silk for sustainability - Oxfordbiomaterials Ltd
http://www.oxfordbiomaterials.com/home/silk-for-sustainability
There are more than 4000 species of silk moth in the world yet only a handful of these are exploited for commercial silk production. The reason for this is that although the cocoons of domesticated mulberry silkworms are easy to unravel, those of non-domesticated species (known as Wild Silkworms) are definitely not. T. Our discovery potentially provides a huge range of new silk-based materials with greatly improved and more consistent mechanical properties, for. A wide range of new applications. Oxford B...
Biomedical Products - Oxfordbiomaterials Ltd
http://www.oxfordbiomaterials.com/home/products
Fluorescent image of nerve growth on Spidrex silk : courtesy of Prof. John Priestley, Center for Neuroscience and Trauma, Queen Mary University London). Silk is an outstanding natural protein combining strength and elasticity. Oxford Biomaterials' unique proprietory treatments render all of its silks perfectly biocompatible without altering their mechanical properties. Additionally, some of our silks have an enhanced affinity for mammalian cells due to the presence of repetitive cell binding amin...Year ...
News and Media - Oxfordbiomaterials Ltd
http://www.oxfordbiomaterials.com/home/news-and-media
October 14th 2015: Oxford Biomaterials voted best pitch. Of its group at the Collaboration Nations event. Https:/ connect.innovateuk.org/web/technologystrategyboard/events-view/-/events/26830442. July 2015: Successful "Development of Prototype" Smart grant awarded to OBM for its haemodialysis graft. May 2015: Successful "Technology Inspired Feasibility study" grant obtained from Innovate UK. The study will last 4 months and investigate a new proprietary process to dissolve silk proteins more effectively.
Recruitment - Oxfordbiomaterials Ltd
http://www.oxfordbiomaterials.com/recruitment
Fluorescent image of nerve growth on Spidrex silk : courtesy of Prof. John Priestley, Center for Neuroscience and Trauma, Queen Mary University London). Latest update : 9th August, 2016 - We are looking for either a Laboratory Technician, or a Research Engineer. If interested, please email your CV, cover letter and expected salary to admin@oxfordbiomaterials.com. No recruitment agents for these positions please-. No recruitment agents please-. Research Engineer Protein-based Biomaterials. The position wi...
TOTAL PAGES IN THIS WEBSITE
8
Environnement – Dico du futur
http://www.dicodufutur.org/category/environnement
LA LETTRE DU FUTUR. LES SITES DES PROPULSEURS. Technicien utilisant des organismes vivants pour détecter et éliminer les pollutions. (suite…). Artisan spécialisée dans la fabrication d’objets biologiques. (suite…). Agriculteur utilisant le numérique et la robotique pour gérer son exploitation. (suite…). Spécialiste de la récupération de l’énergie humaine (suite…). Urbaniste spécialisé dans l’engloutissement des villes. Expert créateur d’objets, pratiques, applications s’inspirant du génie de la nature.
Eotr Solutions - Links
http://www.eotr-solutions.com/links.html
I am an advisor to FirstVentures. They are developing a fund to support early stage companies in the areas of advanced materials and nanotechnology. Oxford Biomaterials started life as Spinox. It is a development by Fritz Vollrath and David Knight of Oxford University. It uses their insight into the production and properties of natural silks to develop a variety of products, primarily in the field of medical implants.
Oxford Spin-out Equity Management: Portfolio
http://www.osem.ox.ac.uk/portfolio/index.html
Pharma tools and services. Industrial applications / cleantech. Other technology (inc. software). The portfolio currently consists of 84 companies. Four of these are listed on AIM, one on LSE and two on NASDAQ, the others are displayed by sector. Since 2000 around 5 companies a year have been added to the portfolio. If you would like to learn more about any of the companies in the current portfolio please contact us. Or refer to the linked company website addresses. Novel technology enabling a digital ca...
Spider-Like Silk
http://ellisdev.co.uk/spider.html
Nottinghamshire, United Kingdom. We are working with Oxford Biomaterials Ltd. And the Department of Zoology at the University of Oxford to develop spider-like silks for a range of applications. Although there is much incorrect information disseminated in the popular press about such silks, they have extremely useful properties when used as a biological material,. We have used one of our specially treated embroidered fibre matrices as a scaffold on which to print cells using ink-jet printers. The cell...
Forskergrupper - biomimetik.dk
http://www.biomimetik.dk/forskergrupper
Her følger en oversigt og kort beskrivelse af forskergrupper og virksomheder i Danmark, Norden og det øvrige udland der aktivt beskæftiger sig med biomimetisk forskning. To view this list in English click here. Lenau’s Group. Technical University of Denmark. Gruppen ledes af Dr. Torben Lenau og forsker i biomimetiske overflader og intelligente materialer og strukturer. De forsøger blandt andet at efterlinge insekters metallisk udseende overflade i kunstige mikro- og nanostrukterer. Dette projekt er et sa...
Orthox | About Orthox
http://www.orthox.co.uk/about-orthox
News & Media. TV & Radio. Awards & IP. Was founded in 2008 by life scientist, Dr Nick Skaer. And knee surgeon, Professor Oliver Kessler. To exploit the potential of silk technology developed at at Oxford University. By Professor Fritz Vollrath’s. Together with Dr David Knight. Professor Vollrath founded Oxford Biomaterials Ltd. To develop and exploit the properties of natural silks for medical applications. The technology they developed was spun out through Isis Innovations. And on Radio New Zealand.
TOTAL LINKS TO THIS WEBSITE
7
Oxford Biochar - Home
Biochar is the carbon rich product obtained by the pyrolysis of biomass (heating under oxygen-deprived conditions). Watch our VIDEO. We are excited to announce new partnerships with Four Seasons Fuel. And the Oxford Charcoal Company. 2016: Oxford Biochar, Coventry University and Garden Organics cooperation on citizen science.
Oxford Bioconcepts
Consultancy to the International Life Science Sector. M: 44 (0)791 2218335. Registered Address: Cox Hinkins and Co, Charterford House, 75 London Road, Oxford, OX3 9BB. Registered in England, No. 6368031.
Home | Oxford Biodynamics
Board & Governance. Chromosome conformation signatures response to methotrexate in early rheumatoid arthritis. Directors Talk highlights OBD’s achievements on ALS project. OBD presents latest ALS biomarker data at the 6th World CNS Summit. Annual Report and Accounts for the year ended 30 Sep 2017 published. Oxford BioDynamics announces grant of Indian patent for its proprietary technology platform, EpiSwitch . We are a biotechnology company with a proprietary biomarker discovery platform, EpiSwitch.
Oxford Bioelectronics | Linking technology with physiology |
Linking technology with physiology. Pioneering advances in the emerging field of bioelectronics. Bioelectronics is an exciting new area of medicine which is transforming the way we think about and treat the human body. Advances in this pioneering field are already being tipped to rewrite the medical textbooks. Gregory B. Diette, MD, MHS. Johns Hopkins University School of medicine. Pulmonologist, Intensivist and Epidemiologist for two decades. He is a member of the American Thoracic Society. Lorem ipsum ...
Home - Oxford Biofules
Here at Oxford Biofuels Ltd, We believe in protecting the environment for "our" future generations. We recycle waste vegetable oil into carbon neutral environmentally green Biodiesel. All waste from the Biodiesel manufacturing process is sent to a anaerobic digestion plant which uses it to produce Biogas. Biogas can then be combusted to produce heat,electricity or road fuel. The solid waste is then used as fertilizer. All this from a waste product! It JUST makes sense!
Oxfordbiomaterials Ltd
March 2018: hiring a Research Engineer- See Recruitment page. Silk for the 21st Century. Oxford Biomaterials Ltd - Magdalen Centre, Oxford Science Park, OX4 4GA, Oxford, UK.
Oxford Biomedical Research | Assay Kits | Biomarker Assay
Skip to main content. Cortisol The Stress Hormone. Our immunoassay is widely used to measure cortisol in many biological fluids and has been used extensively as a biomarker for stress and to monitor adrenal function. Plasminogen Activation is Involved in Fibrinolysis, Cell Adhesion, Apoptosis, and Cell Proliferation. We offer a complete line of plasminogen activators, inhibitors, enzymes, antibodies, and assay kits. The Glutathione S-transferases: A Large Family of Enzymes with Many Roles. CypExpress is ...
OxfordBioMedica |
Skip to main content. Results, reports and presentations. Shareholder meetings, circulars and prospectuses. A video introduction to Oxford BioMedica. A video introduction to Oxford BioMedica. We are working on our own internal product candidates and have interests in a range of partner programmes. Our bioprocessing expertise and facilities support both our own and our partners’ product development. Proposed placing to raise approximately 20.5 million. 44 (0) 1865 783 000.
AIM Rules - OXACO PLC
Updated every 15 minutes. Share Price and RNS. Annual and Interim Reports. The following information is disclosed in accordance with Rule 26 of the AIM Rules:. Description of the business. The names of the directors and biographical details. Directors' responsibilities and Committees. Country of incorporation and main country of operation. OXACO PLC is incorporated in England and Wales (Registration Number 05845469) with England its main country of operation. Number of securities in issue. As an AIM trad...
AIM Rules - OXACO PLC
Updated every 15 minutes. Share Price and RNS. Annual and Interim Reports. The following information is disclosed in accordance with Rule 26 of the AIM Rules:. Description of the business. The names of the directors and biographical details. Directors' responsibilities and Committees. Country of incorporation and main country of operation. OXACO PLC is incorporated in England and Wales (Registration Number 05845469) with England its main country of operation. Number of securities in issue. As an AIM trad...
AIM Rules - OXACO PLC
Updated every 15 minutes. Share Price and RNS. Annual and Interim Reports. The following information is disclosed in accordance with Rule 26 of the AIM Rules:. Description of the business. The names of the directors and biographical details. Directors' responsibilities and Committees. Country of incorporation and main country of operation. OXACO PLC is incorporated in England and Wales (Registration Number 05845469) with England its main country of operation. Number of securities in issue. As an AIM trad...